Concepedia

Blanca Sánchez‐González

BS

40

Publications

2.2K

Citations

24

H-Index

2004

Active since

Affiliations

Hospital Del Mar(Current)

Hospital Universitario La Paz

The University of Texas MD Anderson Cancer Center

Hospital General Universitario Gregorio Marañón

Instituto de Investigación Biomédica de Salamanca

Blanca Sánchez‐González is an author at Hospital Del Mar specializing in medicine, pathology, and cancer research.

ORCID

Top concepts

Publications per year

2004–2023

40

Publications

40

Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia

Guillermo Garcia‐Manero, Hagop M. Kantarjian, Blanca Sánchez‐González et al. · Blood · 2006 · 467 citations · Full text

Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia

Adrian C. Newland, Blanca Sánchez‐González, László Rejtő et al. · American Journal of Hematology · 2019 · 173 citations · Full text

Antileukemia activity of the combination of 5-aza-2′-deoxycytidine with valproic acid

Hui Yang, Koyu Hoshino, Blanca Sánchez‐González et al. · Leukemia Research · 2005 · 162 citations

, , +11

Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

Tomás José González‐López, Cristina Pascual, María Román et al. · American Journal of Hematology · 2014 · 148 citations · Full text

, , +23

Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group)

Ramón García‐Sánz, Anna Sureda, Fátima De la Cruz et al. · Annals of Oncology · 2019 · 121 citations · Full text

Rows per page

1–5 of 40